FedOps
Highlights
Awards & Opportunities
Contracts
Agencies
Companies
Saved
Light
Light
Clear all
Search
Awards and Opportunities
Showing 1–1 of 1
Updated Oct 2, 2026, 2:00 AM UTC
CSV
Awardee: KALEO, INC.
Award
No Set aside used
$340.9M
Copy link
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
view on SAM.gov
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
› BARDA - ASPR / DAAPPO / BARDA DCMA
Posted Sep 30, 2026
Washington, DC
NAICS 541714 – Research and Development in Biotechnology (except Nanobiotechnology)
Sol # 75A50126C00010
Awardee:
KALEO, INC.
AI Summary
Copy
• BARDA requires development and procurement of 2-PAM autoinjectors to treat organophosphate poisoning.
• This acquisition is unrestricted, with no specified set-aside program.
• Development includes late-stage clinical and regulatory approval for adult and pediatric populations.
• Procurement is for the SNS/CHEMPACK Program.
Show details
FedOps